Back
Royalty Pharma PLC Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
RPRX
Royalty Pharma PLC
Last Price:
$32.85
Seasonality Move:
0.5%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RPRX is experiencing slight buying pressure.
Royalty Pharma PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.69 | Buy |
20-day SMA: | 32.92 | Sell |
50-day SMA: | 32.44 | Buy |
200-day SMA: | 29.57 | Buy |
8-day EMA: | 32.78 | Buy |
20-day EMA: | 32.79 | Buy |
50-day EMA: | 32.49 | Buy |
200-day EMA: | 30.5 | Buy |
Royalty Pharma PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 51.49 | Buy |
Chaikin Money Flow: | 9739160 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.35 - 33.33) | Buy |
Bollinger Bands (100): | (30.65 - 33.59) | Buy |
Royalty Pharma PLC Technical Analysis
May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Royalty Pharma PLC Stock
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 32.88 while RPRX 8-day simple moving average is 32.69, which is a Buy signal.
-
The stock price of RPRX is 32.88 while Royalty Pharma PLC 20-day SMA is 32.92, which makes it a Sell.
-
Royalty Pharma PLC 50-day simple moving average is 32.44 while RPRX share price is 32.88, making it a Buy technically.
-
RPRX stock price is 32.88 and Royalty Pharma PLC 200-day simple moving average is 29.57, creating a Buy signal.
RPRX Technical Analysis vs Fundamental Analysis
Sell
50
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy or a Sell?
-
Royalty Pharma PLC stock is rated a SellThe current Royalty Pharma PLC [RPRX] share price is $32.88. The Score for RPRX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Royalty Pharma PLC Stock Info
Market Cap:
13.9B
Price in USD:
32.88
Share Volume:
22.2M
Royalty Pharma PLC 52-Week Range
52-Week High:
34.32
52-Week Low:
24.05
Sell
50
Royalty Pharma PLC (RPRX)
is a Sell
Royalty Pharma PLC Share Price Forecast
-
What is the Royalty Pharma PLC stock price today?The Royalty Pharma PLC stock price is 32.88 USD today.
-
Will RPRX stock go up or go down?Royalty Pharma PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Royalty Pharma PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma PLC is overvalued.
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 32.88 while RPRX 8-day exponential moving average is 32.78, which is a Buy signal.
-
The stock price of RPRX is 32.88 while Royalty Pharma PLC 20-day EMA is 32.79, which makes it a Buy.
-
Royalty Pharma PLC 50-day exponential moving average is 32.49 while RPRX share price is 32.88, making it a Buy technically.
-
RPRX stock price is 32.88 and Royalty Pharma PLC 200-day simple moving average is 30.50, creating a Buy signal.
Fundamental Analysis of Royalty Pharma PLC
Is Royalty Pharma PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.45 per share, an increase this year of $0.37 per share, and an increase next year of $0.62 per share.
Technical Analysis of Royalty Pharma PLC
Should I short Royalty Pharma PLC stock?
-
RPRX Moving Average Covergence Divergence (MACD) indicator is 0.07, suggesting Royalty Pharma PLC is a Buy
-
Royalty Pharma PLC Relative Strength Index (RSI) is 51.49, which suggest Royalty Pharma PLC is overbought
-
The Bollinger Bands (25) for Royalty Pharma PLC is (32.35 - 33.33), which suggest Royalty Pharma PLC is a Buy
-
The Bollinger Bands (100) for Royalty Pharma PLC is (30.65 - 33.59), which suggest Royalty Pharma PLC is a Buy
* Royalty Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.